Porcine epidemic diarrhea vaccines market to reach $2.5 billion by 2030 at 6.7% cagr, driven by increasing pig farming supported by rising global demand for pork.
Read More
Pontine glioma drugs market to reach $1.74 billion by 2030 at 9.8% CAGR, driven by rising demand for personalized medicine.
Read More
Polydeoxyribonucleotide (pdrn) repair ampoule market to reach $0.86 billion by 2030 at 12.4% CAGR, driven by increasing demand for non-surgical aesthetic procedures.
Read More
Polyclonal antibodies market to reach $2.1 billion by 2030 at 7.3% CAGR, driven by increasing prevalence of cancer.
Read More
Point of care connectivity solutions market to reach $2.13 billion by 2030 at 9.8% CAGR, driven by rising prevalence of diabetes.
Read More
Pneumococcal vaccine market to reach $12.76 billion by 2030 at 6.5% CAGR, driven by increasing prevalence of pneumococcal contamination.
Read More
Pms and menstrual health supplements market to reach $40.39 billion by 2030 at 8.1% CAGR, driven by increasing prevalence of polycystic ovary syndrome (pcos).
Read More
Plexiform neurofibroma treatment market to reach $2.14 billion by 2030 at 8.1% CAGR, driven by increasing demand for personalized medicine.
Read More
Plasmid purification market to reach $4.44 billion by 2030 at 14.4% CAGR, driven by increasing demand for gene therapies.
Read More
The global plasma therapy market to reach $1.13 billion by 2030 at 13.0% CAGR, driven by rising cases of osteoarthritis.
Read More